Hemant Damodar Pathak

Vaishali Pharma Ltd, an esteemed organization established in the year 1989. We have evolved from a PAN-India raw material trader into a diversified pharmaceutical powerhouse. Today, we offer a comprehensive range of portfolio encompassing Active Pharmaceutical Ingredients (APIs), Finished Formulations, Surgical, Herbals, Veterinary products, Nutraceuticals, Oncology, and the newly added Contrast Media. We went public, got listed in the Indian Stock Exchange NSE on 15th January 2020 and continuously focused on delivering the best results. We comply with all the regulatory requirement of different countries with their respective rules, regulations and documentations. The 'Vaishalians Code of conduct’ provides a strong framework for business ethics by balancing our corporate values through Integrity, Customer centric approach, Innovation, Passion, Productivity and Adaptability. Our products are manufactured with stringent quality procedures providing the best results, strong and hard to withstand any mechanical shock during manufacturing, packing, shipping, dispensing, and use releasing its content in a predictable and reproducible manner providing reasonable physical and chemical stability. Global Reach & Expertise: • 45+ countries served with 150+ dossiers in CTD and ACTD format ready. • Dedicated in-house regulatory and design teams for seamless client service. • Strong presence in Africa, CIS countries, and Southeast Asia. Unwavering Quality: • EU GMP, WHO GMP (finished formulations), HALAL certified (nutraceuticals), USFDA (nutraceuticals/food supplements), ISO, and CE (surgical) certifications. • 30+ years of industry experience and robust supplier networks ensure competitive edge and quality materials. Connect with Us: We are committed to collaborating with healthcare professionals worldwide to improve patient outcomes. Connect with us to explore partnerships, discuss specific needs, or stay updated on the latest pharmaceutical advancements.